Heron Therapeutics | Umsatzkosten

Aktienkurs
1.21
Täglich Wechseln
0.01 0.83%
Monatlich
-8.33%
Jährlich
-52.55%
Q1 Prognose
1.15




Umsatzkosten Veränderung Datum
ALKERMES USD 46.21M 5.38M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amarin USD 16.89M 18.51M 2025-03
ANI Pharmaceuticals USD 122.88M 6.86M 2025-12
Anika Therapeutics USD 11.49M 35.48M 2025-03
Eisai JPY 51.08B 5.56B 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 51.63M 22.2M 2024-09
GlaxoSmithKline GBP 2.61B 377M 2025-12
Heron Therapeutics USD 9.46M 1.61M 2024-09
Insmed USD 46.16M 15.25M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
Merck USD 3.32B 531M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 54.62M 6.02M 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Surmodics USD 33.03M 24.58M 2024-09
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Veracyte USD 39.28M 1.93M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12


Heron Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.